Camtek Ltd., together with its subsidiaries, develops, manufactures, and sells inspection and metrology equipment for semiconductor industry in the United States, China, Korea, Europe, and the Asia Pacific.
FAIL · Does not pass the screen
153.79 USD
Screen close, 2026-10-01 · not a live quote Last reviewed 4 days ago
Screened 2026-10-01 · the tape above runs as of 05:02 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 153.79 against the desk's fair-value range, base estimate 113.98, over the last year.
Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical does not pass the values gate
Price153.79 USD
Fair value113.98
Ethical score70.0/100
Our investment reviews on this name
2026-10-02Read Markup153.79+0.0% to today ✓
2026-07-02Read Distribution193.27-20.4% to today ✓
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Camtek Ltd. holds its Accumulation at $153.79. The statistical read favours the buyers, held for 11 days.
As held on the ledger · 2026-10-01
Phase
Accumulation
Quantitative state
The statistical read favours the buyers, held for 11 days
Price at the screen
$153.79
Valuation
210.67 trailing · 32.11 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.59
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
42.13%
Below 33%
Interest-bearing debt is 42.1% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
14.52%
Below 33%
Cash held in interest-bearing accounts and securities is 14.5% of assets, under the one-third limit.
Pass
Receivables
21.33%
Below 49%
Money owed to the company is 21.3% of assets, under the 49% limit.
Pass
Revenue purity
5.85%
Below 5%
5.9% of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Camtek's business is in a permissible area, but its interest-bearing debt is about 42% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-04. It updates when the underlying figures move, and past reads are kept below.
Fair value range in USD, drawn from the 2026-10-01 screen. The gold marker is the market price at the same screen. The price runs 25.9% above the base estimate.
Third-party analyst targets: 10 covering, consensus Buy. The average target sits +22% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-01 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Chip tools caught in a slowing cycle
Every time a new chip fab ramps up or a packaging line gets tuned, the inspection gear has to keep pace with ever-smaller features and higher volumes. Camtek sits in that niche, yet its revenue is growing just 2 percent while the forward multiple sits at 32 times. Our fair value sits 23 percent below the current price, and the business earns only an 8 percent return on equity with thin 10 percent margins.
We pass because the numbers do not justify the valuation in a cyclical industry. Low growth and modest profitability often signal peak earnings rather than a bargain multiple, and the market's buy ratings with a 188 dollar median target ignore how quickly orders can vanish when memory or logic spending turns.
Currency swings, customer concentration in Asia, and the unknown competitive edge add real downside if the cycle rolls over. Ethical screens clear, yet the risk-reward does not.
The risks · The things to watch: it already moves more than the market on an average day; its business and earnings are exposed to Israel and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
CAMT trades on Nasdaq (the company is based in Israel). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-02Markup · changed$153.79+2.8%Entry 6
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 31% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 121%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (12 analysts) rates it none, with a mean price target of $187.
2026-08-24Distribution$149.67+2.4%Entry 5
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 31% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 121%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (12 analysts) rates it none, with a mean price target of $187.
2026-07-24Distribution$146.15-24.4%Entry 4
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 24.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 31% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 121%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (12 analysts) rates it none, with a mean price target of $187.
2026-07-18Distribution$193.27+0.0%Entry 3
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 31% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 121%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (12 analysts) rates it none, with a mean price target of $187.
2026-07-03Distribution$193.27+0.0%Entry 2
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Distribution$193.27Entry 1
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
